Guardant Health, Inc. (GH) Stock Overview
Explore Guardant Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Guardant Health, Inc. (GH)
Key Financials
Key Financials
Market Cap
23.2B
P/E Ratio
-49.21
EPS (TTM)
$-3.49
ROE
2.11%
GH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Guardant Health, Inc. (NASDAQ: GH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Guardant Health, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of GH on the NASDAQ shows an RSI of 55.71, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $168.45 for the NASDAQ listing.
Key metrics behind Guardant Health, Inc.'s NASDAQ-traded stock include a P/E ratio of -49.21 and a market capitalization of 23.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GH on the NASDAQ.